T1	Participants 25 44	hairy cell leukemia
T2	Participants 71 108	69 patients treated from 1983 to 1986
T3	Participants 146 260	69 hairy cell leukemia (HCL) patients treated with interferon alfa-2b (IFN) as primary treatment from 1983 to 1986
T4	Participants 353 431	61 patients completing the intended 12 or more months of initial IFN treatment
